Amiee Kang
About
Amiee Kang is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics.
According to data from OpenAlex, Amiee Kang has authored 31 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 7 papers in Economics and Econometrics. Recurrent topics in Amiee Kang's work include Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (14 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Amiee Kang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (14 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Amiee Kang collaborates with scholars based in United States, United Kingdom and Denmark. Amiee Kang's co-authors include Xuemei Luo, Allison Keshishian, Gregory Y.H. Lip, Hüseyin Yüce, Amol D. Dhamane, Steven Deitelzweig, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang and Manuela Di Fusco and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Cardiology.
In The Last Decade
Amiee Kang
29 papers receiving 386 citations
Peers
Amiee Kang
David Evans United Kingdom
Pil‐Sung Yang South Korea
José Polo García Spain
Sergio Cinza‐Sanjurjo Spain
Gustavo B.F. Oliveira Brazil
M. Pfannkuche Germany
Christian Klem United States
Carmen Suárez Fernández Spain
Lesley Maisch United States
Citations per year, relative to Amiee Kang Amiee Kang (= 1×)
peers
David Evans
Countries citing papers authored by Amiee Kang
Since
Specialization
Citations
This map shows the geographic impact of Amiee Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amiee Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amiee Kang more than expected).
Fields of papers citing papers by Amiee Kang
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Amiee Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amiee Kang. The network helps show where Amiee Kang may publish in the future.
Co-authorship network of co-authors of Amiee Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Amiee Kang. A scholar is included among the top collaborators of Amiee Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amiee Kang. Amiee Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kang, Amiee, et al.. (2025). Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation Who Switched from Warfarin to Direct Oral Anticoagulants in Medicare Population. Advances in Therapy. 42(3). 1462–1483.
2.
Atwater, Brett D., et al.. (2025). Geographic and Racial Variation in Oral Anticoagulant (OAC) Treatment Among Commercially Insured Patients with Non-valvular Atrial Fibrillation (NVAF) in the United States. American Journal of Cardiovascular Drugs. 25(5). 667–679.
3.
Lip, Gregory Y.H., Amiee Kang, Xuemei Luo, et al.. (2024). Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims. Journal of Thrombosis and Thrombolysis. 57(6). 1092–1102.
4.
Deitelzweig, Steven, Amiee Kang, Jenny Jiang, et al.. (2024). Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation. Journal of Clinical Medicine. 13(4). 1073–1073.
5.
Deitelzweig, Steven, Manuela Di Fusco, Amiee Kang, et al.. (2022). Real-world Evidence Comparing Oral Anticoagulants in non-valvular Atrial Fibrillation: A Systematic Review and Network meta-analysis. Future Cardiology. 18(5). 393–405.
6.
Lip, Gregory Y.H., Allison Keshishian, Amiee Kang, et al.. (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. Journal of Thrombosis and Thrombolysis. 54(1). 33–46.
7.
Deitelzweig, Steven, Allison Keshishian, Amiee Kang, et al.. (2022). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. European Journal of Internal Medicine. 108. 37–42.
8.
Deitelzweig, Steven, Amiee Kang, Cristina Russ, et al.. (2021). EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS. Journal of the American College of Cardiology. 77(18). 1593–1593.
9.
Deitelzweig, Steve, Amiee Kang, Cristina Russ, et al.. (2021). Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs. The American Journal of Cardiology. 163. 43–49.
10.
Deitelzweig, Steven, Allison Keshishian, Yan Zhang, et al.. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC CardioOncology. 3(3). 411–424.
11.
Fusco, Manuela Di, Carlos Polanco, Amiee Kang, et al.. (2021). Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. PLoS ONE. 16(11). e0259251–e0259251.
12.
Lip, Gregory Y.H., Allison Keshishian, Amiee Kang, et al.. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Mayo Clinic Proceedings. 95(5). 929–943.
13.
Lópes, Renato D., Samantha Berger, Manuela Di Fusco, et al.. (2020). A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation. International Journal of Cardiology. 319. 85–93.
14.
Deitelzweig, Steven, Allison Keshishian, Amiee Kang, et al.. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. Journal of the American College of Cardiology. 73(9). 435–435.
15.
Asche, Carl V., Simon Dagenais, Amiee Kang, Jinma Ren, & Brian T. Maurer. (2019). Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty. Journal of Medical Economics. 22(12). 1253–1260.
16.
Asche, Carl V., Simon Dagenais, Amiee Kang, Jinma Ren, & Brian T. Maurer. (2018). Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions. Journal of Medical Economics. 22(1). 85–94.
17.
DiGiacomo, J. Christopher, et al.. (2017). Mortality is predicted by Comorbidity Polypharmacy score but not Charlson Comorbidity Index in geriatric trauma patients. The American Journal of Surgery. 216(1). 42–45.
18.
Angus, L. D. George, et al.. (2016). COMPARISON OF INTRAOPERATIVE KETAMINE VS. FENTANYL USE DECREASES POSTOPERATIVE OPIOID REQUIREMENTS IN TRAUMA PATIENTS UNDERGOING CERVICAL SPINE SURGERY.. PubMed. 23(4). 415–20.
19.
Echeverría, Sandra E., et al.. (2013). A Community Survey on Neighborhood Violence, Park Use, and Physical Activity Among Urban Youth. Journal of Physical Activity and Health. 11(1). 186–194.
20.
Romanelli, Robert J., et al.. (2013). Multivariate Analysis of Factors Associated With Persistent Colesevelam Treatment Among Patients With Hypercholesterolemia. Annals of Pharmacotherapy. 47(10). 1247–1252.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David Evans Breakdown of academic impact, for papers by Pil‐Sung Yang Breakdown of academic impact, for papers by José Polo García Breakdown of academic impact, for papers by Sergio Cinza‐Sanjurjo Breakdown of academic impact, for papers by Gustavo B.F. Oliveira Breakdown of academic impact, for papers by M. Pfannkuche Breakdown of academic impact, for papers by Christian Klem Breakdown of academic impact, for papers by Carmen Suárez Fernández Breakdown of academic impact, for papers by Lesley Maisch